DRUG Operating Cash Flow (Statement)
Bright Minds Biosciences Inc · Operating Cash Flow (Statement)
DRUG Operating Cash Flow (Statement)
Latest reported-$25.00M CADperiod ending
DRUG TTM Cash from Operations · CAD (-$288.39K → -$25.00M)
TTM operating cash flow (statement)
High-resolution chart · PNG
DRUG operating cash flow (statement) history
Trailing twelve months (TTM) · CAD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (CAD) |
|---|---|
| -24,998,790 | |
| -20,084,095 | |
| -13,013,126 | |
| -8,691,619 | |
| -7,886,781 | |
| -4,142,686 | |
| -2,522,493 | |
| -1,850,186 | |
| -2,584,540 | |
| -4,475,248 | |
| -5,182,680 | |
| -7,024,265 | |
| -7,955,335 | |
| -9,166,863 | |
| -11,299,817 | |
| -13,587,116 | |
| -13,848,091 | |
| -13,958,764 | |
| -11,720,754 | |
| -7,319,301 | |
| -5,140,363 | |
| -2,147,819 | |
| -778,177 | |
| -288,392 |